Medicare Advantage 2027 Payment Rates Hide a $13 Billion Shift That Will Reshape Provider Contracts

The 2.48% Medicare Advantage rate increase for 2027 looks modest on paper, but it conceals a fundamental shift in how plans will calculate risk and negotiate with providers.

CMS is injecting over $13 billion in additional MA payments to plans while simultaneously tightening the screws on risk adjustment methodology. When accounting for estimated risk score trend, the actual increase reaches 4.98%, creating a gap that will force plans to recalibrate their provider payment strategies.

Risk Adjustment Gets Real Consequences

Starting in 2027, CMS will exclude diagnosis information from unlinked chart review records from risk score calculations. This technical change has immediate financial implications for any provider group with loose documentation practices or inconsistent coding workflows.

Plans that have relied on aggressive chart reviews to boost risk scores will see their reimbursement compress. They'll push that pressure downstream to providers through tighter contract terms, enhanced documentation requirements, and more stringent coding audits. Surgery centers and medical groups that haven't invested in coding accuracy will find themselves squeezed between declining MA reimbursement and rising administrative costs to meet new documentation standards.

The Contract Year 2027 Final Rule also introduces changes to quality bonus payments and Star Ratings, adding another layer of performance pressure that plans will translate into provider contract requirements.

Why Your Bottom Line Will Feel This

The math is straightforward but the timing is compressed. MA plans have less than 18 months to adjust their networks, renegotiate contracts, and implement new risk management protocols. Plans facing the biggest risk adjustment hits will move fastest to transfer that financial pressure to providers.

Expect to see contract renewals that include:
- Enhanced documentation and coding audit clauses
- Quality metrics tied directly to Star Rating components
- Shared risk arrangements that shift documentation liability to provider groups
- Reduced fee schedules for groups that can't demonstrate coding accuracy

For ASCs and medical groups with significant MA patient volumes, the 2027 changes create a narrow window to demonstrate value beyond just competitive pricing. Plans will prioritize partners who can help them maintain risk scores under the new methodology while meeting enhanced quality requirements.

What to Monitor Through 2026

Track your MA plan partners' current Star Ratings and quality bonus status. Plans with lower ratings face the steepest climb under the new requirements and will likely demand the most aggressive contract modifications.

Watch for early signals in 2026 contract negotiations. Plans testing new documentation requirements or proposing shared risk arrangements are likely positioning for the 2027 changes. Groups that can demonstrate superior coding accuracy and quality outcomes now will have more negotiating leverage as plans scramble to meet the new standards.

Monitor your own documentation and coding performance metrics. The providers who emerge strongest from 2027 will be those who can prove their processes actually help plans maintain risk scores rather than just generate patient volume. Start building that evidence base now, before your next contract renewal puts it to the test.